Supraglip-M Forte Tablet SR

Supraglip-M Forte Tablet SR is prescribed to manage type 2 diabetes mellitus.

It belongs to the class of biguanide medications that work by reducing glucose production in the liver and increasing insulin sensitivity in tissues.

 While teneligliptin is classified as a dipeptidyl peptidase4 (DPP4) inhibitor functions by increasing the activity of incretin hormones, which stimulate insulin release and reduce the secretion of glucagon.

Inform your doctor about any existing medical conditions, allergies, or medications you are currently taking before starting this combination.

Monitor blood sugar levels regularly and attend follow-up appointments as advised by your doctor.

Patients prescribed it should adhere to their healthcare provider's recommendations regarding dosage and duration of treatment.

It is crucial to report any persistent symptoms or adverse effects promptly.